Abstract:
Sufferers of type two diabetes may soon be able to inhale their treatment, rather than inject it, thanks to Melbourne researchers. The researchers have re-engineered the insulin molecule. They have shrunk it - using the technology that makes decaffeinated coffee - and improved its ability to be absorbed by the human body. "You basically dissolve the drugs in super critical fluids and then, by variations in temperatures and pressures and other parameters, you produce nano-sized drug particles."